Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
AUTOR(ES)
Kulwichit, Wanla
FONTE
The National Academy of Sciences
RESUMO
The latent membrane protein 1 (LMP1) of the Epstein–Barr virus has transforming properties in rodent fibroblasts and is expressed in most of the cancers associated with Epstein–Barr virus (EBV) infection including posttransplant lymphomas, Hodgkin’s disease, nasopharyngeal carcinoma, and AIDS-related lymphomas. In this study, three lineages of LMP1 transgenic mice were established with LMP1 expressed under the control of the Ig heavy chain promoter and enhancer. Lymphoma developed in all three lineages, and the incidence of lymphoma increased significantly with age with lymphomas developing in 42% of transgenic mice over 18 months. The expression of LMP1 was detected at high levels in the lymphoma tissues but only at trace levels in normal lymphoid tissues. Gene rearrangement of the Ig heavy chain indicated monoclonality or oligoclonality in all lymphomas, some of the lymphoid hyperplastic spleens, and some histologically normal spleens. These data reveal that LMP1, without the expression of other EBV genes, is oncogenic in vivo and indicate that LMP1 is a major contributing factor to the development of EBV-associated lymphomas.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21748Documentos Relacionados
- Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
- The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.
- Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
- Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
- Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-κB Signaling Pathway